Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

271 ARTÍCULOS , VIENDO DEL 226 AL 240

Non-invasive Biomarkers for Early Detection of Alzheimer's Disease: a New-Age Perspective

Chimthanawala NMA, Haria A, Sathaye S.

Mol Neurobiol. 2024 Jan;61(1):212-223. doi: 10.1007/s12035-023-03578-3. Epub 2023 Aug 19.

Molecular basis of selective amyloid-β degrading enzymes in Alzheimer's disease

Żukowska J, Moss SJ, Subramanian V, Acharya KR.

FEBS J. 2024 Jul;291(14):2999-3029. doi: 10.1111/febs.16939. Epub 2023 Sep 8.

Association of metabolic dysfunction with cognitive decline and Alzheimer's disease: A review of metabolomic evidence

Amidfar M, Askari G, Kim YK.

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Jan 10;128:110848. doi: 10.1016/j.pnpbp.2023.110848. Epub 2023 Aug 25.

Subcellular proteomics insights into Alzheimer's disease development

Liang Z, Zhuang H, Cao X, Ma G, Shen L.

Proteomics Clin Appl. 2024 May;18(3):e2200112. doi: 10.1002/prca.202200112. Epub 2023 Aug 31.

Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles

Su H, Masters CL, Bush AI, Barnham KJ, Reid GE, Vella LJ.

Proteomics. 2024 Jun;24(11):e2300063. doi: 10.1002/pmic.202300063. Epub 2023 Aug 31.

Anti-amyloid antibody treatments for Alzheimer's disease

Perneczky R, Dom G, Chan A, Falkai P, Bassetti C.

Eur J Neurol. 2024 Feb;31(2):e16049. doi: 10.1111/ene.16049. Epub 2023 Sep 11.

The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022

Veitch DP, Weiner MW, Miller M, Aisen PS, Ashford MA, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nho KT, Nosheny R, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin A, Shaw LM, Toga AW, Tosun D; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12.

Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network

Wagemann O, Li Y, Hassenstab J, Aschenbrenner AJ, McKay NS, Gordon BA, Benzinger TLS, Xiong C, Cruchaga C, Renton AE, Perrin RJ, Berman SB, Chhatwal JP, Farlow MR, Day GS, Ikeuchi T, Jucker M, Lopera F, Mori H, Noble JM, Sánchez-Valle R, Schofield PR, Morris JC, Daniels A, Levin J, Bateman RJ, McDade E, Llibre-Guerra JJ; Dominantly Inherited Alzheimer Network.

Alzheimers Dement. 2024 Jan;20(1):47-62. doi: 10.1002/alz.13460. Epub 2023 Sep 23.

The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partners Scientific Board (PPSB)

Albala B, Appelmans E, Burress R, De Santi S, Devins T, Klein G, Logovinsky V, Novak GP, Ribeiro K, Schmidt ME, Schwarz AJ, Scott D, Shcherbinin S, Siemers E, Travaglia A, Weber CJ, White L, Wolf-Rodda J, Vasanthakumar A.

Alzheimers Dement. 2024 Jan;20(1):695-708. doi: 10.1002/alz.13483. Epub 2023 Sep 29.

Exosomes in multiple sclerosis and Alzheimer's disease - Adversary and ally

Tang N.

Biomed J. 2024 Oct;47(5):100665. doi: 10.1016/j.bj.2023.100665. Epub 2023 Sep 29.

Neprilysin inhibitors and risk of Alzheimer's disease: A future perspective

Ali NH, Al-Kuraishy HM, Al-Gareeb AI, Alnaaim SA, Alexiou A, Papadakis M, Khalifa AA, Saad HM, Batiha GE.

J Cell Mol Med. 2024 Jan;28(2):e17993. doi: 10.1111/jcmm.17993. Epub 2023 Oct 17.

Advances in targeted tracking and detection of soluble amyloid-β aggregates as a biomarker of Alzheimer's disease

Gao H, Chen J, Huang Y, Zhao R.

Talanta. 2024 Feb 1;268(Pt 1):125311. doi: 10.1016/j.talanta.2023.125311. Epub 2023 Oct 14.

Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics

Muir RT, Ismail Z, Black SE, Smith EE.

Alzheimers Dement. 2024 Feb;20(2):1436-1458. doi: 10.1002/alz.13510. Epub 2023 Oct 31.

Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study

Vrillon A, Ashton NJ, Karikari TK, Götze K, Cognat E, Dumurgier J, Lilamand M, Zetterberg H, Blennow K, Paquet C.

J Neurol. 2024 Mar;271(3):1297-1310. doi: 10.1007/s00415-023-12066-6. Epub 2023 Nov 11.

Innovative SALDI mass spectrometry analysis for Alzheimer's disease synthetic peptides detection

Cournut A, Moustiez P, Coffinier Y, Enjalbal C, Bich C.

Talanta. 2024 Feb 1;268(Pt 2):125357. doi: 10.1016/j.talanta.2023.125357. Epub 2023 Nov 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias